Patents by Inventor Anthony Winiski

Anthony Winiski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-arylsulfonyl-2,3-dihydro-1H-indoles and the use thereof as CCR9 inhibitors
    Patent number: 7781481
    Abstract: N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: August 24, 2010
    Assignee: Novartis AG
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of CCR9 activity
    Patent number: 7759390
    Abstract: Compounds of formula I, wherein one of R1 and R2 is thienyl which is substituted by halogen and the other of R1 and R2 is substituted phenyl, wherein the substituents are as defined in the claims, with the proviso that the phenyl group is substituted by at least a cyano, carboxy or (C1-4)alkyloxycarbonyl group, are inhibitors of CCR9 activity and useful for therapeutic treatment.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: July 20, 2010
    Assignee: Novartis AG
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Pharmaceutically Active Benzensulphonyl-Indols
    Publication number: 20100075963
    Abstract: 1-Benzenesulfonyl-1H-indoles, processes for their production and their use as pharmaceuticals, e.g. in the treatment of disorders which are mediated by CCR9, such as e.g. inflammatory bowel disease.
    Type: Application
    Filed: February 4, 2008
    Publication date: March 25, 2010
    Applicant: NOVARTIS AG
    Inventors: Philipp Lehr, Anthony Winiski
  • Inhibitors of Ccr9 Activity
    Publication number: 20080312313
    Abstract: A compound of formula (I), wherein the residues have various meanings, useful as pharmaceuticals.
    Type: Application
    Filed: December 22, 2006
    Publication date: December 18, 2008
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of Ccr9 Activity
    Publication number: 20080300295
    Abstract: Compounds of formula I, wherein one of R1 and R2 is thienyl which is substituted by halogen and the other of R1 and R2 is substituted phenyl, wherein the substituents are as defined in the claims, with the proviso that the phenyl group is substituted by at least a cyano, carboxy or (C1-4)alkyloxycarbonyl group, are inhibitors of CCR9 activity and useful for therapeutic treatment.
    Type: Application
    Filed: December 22, 2006
    Publication date: December 4, 2008
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of Ccr9 Activity
    Publication number: 20080275114
    Abstract: Compounds of formula (I), in which R1 and R2 are independently a substituted phenyl group, where the substituents are as defined in the claims and with the proviso that at least one of the substituents is a cyano, carboxy or (C1-4)alkoxycarbonyl group, are inhibitors of CCR9 activity useful for therapeutic treatment, particularly of irritable bowel disease.
    Type: Application
    Filed: December 22, 2006
    Publication date: November 6, 2008
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Inhibitors of Ccr9 Activity
    Publication number: 20080269312
    Abstract: N-(benzenesulphonyl)-2,3-dihydro-1H-indols, wherein the indol is substituted by cyano, carboxy or alkylcarbonyloxy and their use as therapeutical agents.
    Type: Application
    Filed: December 12, 2006
    Publication date: October 30, 2008
    Inventors: Jose M. Carballido Herrera, Herbert Jaksche, Philipp Lehr, Gudrun Werner, Anthony Winiski
  • Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases
    Publication number: 20060083754
    Abstract: The use of a combination of a corticoid and a compound of formula I for the preparation of a medicament for the treatment of a corticoid-resistant disease and/or a calcineurin inhibitor-resistant disease, e.g. where T cells are involved in the pathophysiology.
    Type: Application
    Filed: February 9, 2004
    Publication date: April 20, 2006
    Inventor: Anthony Winiski